Research programme: Oncology therapeutics - Schrodinger
Latest Information Update: 04 Jan 2024
At a glance
- Originator Schrodinger
- Class Antineoplastics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 29 Nov 2023 Early research in Cancer in USA (Schrodinger pipeline, November 2023)